Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof

Patent metadata

Field	Value
Publication number	US-8940884-B2
Application number	US-72785110-A
Country	US
Kind code	B2
Filing date	Mar 19, 2010
Priority date	Mar 19, 2009
Publication date	Jan 27, 2015
Grant date	Jan 27, 2015

Abstract

The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof.

First claim

What is claimed is:

1. A method of identifying a nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide comprising PUFA synthase activity of ER activity and DH activity, the method comprising: screening for a nucleic acid molecule from an organism that hybridizes to the complement of a polynucleotide sequence at least 95% identical to SEQ ID NO:5 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 95% identical to SEQ ID NO:6, and determining the PUFA synthase activity of the nucleic acid molecule that hybridizes, wherein the nucleic acid molecule is capable of hybridizing under stringency conditions comprising post-hybridization washes selected from the group consisting of: (1) a series of washes starting with 6×SSC and 0.5% SDS at room temperature for 15 min., then repeated with 2×SSC and 0.5% SDS at 45° C. for 30 min., and then repeated twice with 0.2×SSC and 0.5% SDS at 50° C. for 30 min.; (2) a series of washes starting with 6×SSC and 0.5% SDS at room temperature for 15 min., then repeated with 2×SSC and 0.5% SDS at 45° C. for 30 min., and then repeated twice with 0.2×SSC and 0.5% SDS at 60° C. for 30 min.; and (3) a series of washes starting with 6×SSC and 0.5% SDS at room temperature for 15 min., then repeated with 2×SSC and 0.5% SDS at 45° C. for 30 min., and then repeated twice with 0.1×SSC and 0.1% SDS at 65° C.

2. A recombinant nucleic acid molecule comprising a polynucleotide sequence at least 95% identical to SEQ ID NO:5 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 95% identical to SEQ ID NO:6, and a transcription control sequence, wherein said polynucleotide sequence is heterologous to said transcription control sequence.

3. A host cell that expresses a nucleic acid molecule comprising a polynucleotide sequence at least 95% identical to SEQ ID NO:5 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 95% identical to SEQ ID NO:6, wherein said nucleic acid molecule is heterologous to the host cell, and wherein said host cell is not a human cell.

4. The host cell of claim 3 , wherein the host cell is selected from the group consisting of a plant cell, a microbial cell, and an isolated animal cell.

5. The host cell of claim 4 , wherein the microbial cell is a thraustochytrid, excluding Schizochytrium sp. ATCC PTA-9695.

6. The host cell of claim 5 , wherein the thraustochytrid is a Schizochytrium or a Thraustochytrium , excluding Schizochytrium sp. ATCC PTA-9695.

7. The host cell of claim 4 , wherein the plant cell is selected from the group consisting of: canola, soybean, rapeseed, linseed/flax, maize, safflower, sunflower, tobacco, Arabidopsis thaliana , Brazil nut, castor bean, coconut, coriander, cotton, groundnut, jojoba, mustard, oil palm, olive, rice, squash, barley, wheat, and duckweed.

Assignees

• Apt Kirk E
• Richter Leslie
• Simpson David
• Zirkle Ross
• Dsm Ip Assets Bv

Inventors

• Apt Kirk E
• Richter Leslie
• Simpson David
• Zirkle Ross

Classifications

• A61P3/00

  Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title

• C12Y203/01041

  Beta-ketoacyl-acyl-carrier-protein synthase I (2.3.1.41) · CPC title

• C12Y101/01

  with NAD+ or NADP+ as acceptor (1.1.1) · CPC title

• A61K38/00

  Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title

• C12N15/8247

  involving modified lipid metabolism, e.g. seed oil composition · CPC title